BEND4: a novel prognostic biomarker in diffuse large B-cell lymphoma

BEND4: a novel prognostic biomarker in diffuse large B-cell lymphoma

Abstract Background BEN domain-containing protein 4 (BEND4) is implicated in various cancer-related processes, but its role in diffuse large B-cell lymphoma (DLBCL) remains unclear. This study examined BEND4’s impact on DLBCL prognosis through bioinformatics analysis. Methods BEND4 expression was an...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanfang Wang, Zhenhao Zhang, Lianyong Xi, Hua Wang, Fei Dong
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
BEND4
Diffuse large B-cell lymphoma
TCGA
Biomarker
Prognosis
Immune infiltration
Online Access:https://doi.org/10.1007/s12672-025-02519-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items